New York Life Investment Management’s IQ Global Equity R&D Leaders ETF WRND Stock Holding History

New York Life Investment Management’s Portfolio WRND Stock Details WRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16M	Buy	380,000 +190,000	+100%	+$7.78M	0.11%	155
2026 Q1	$6.81M	Hold	190,000	–	–	0.06%	268
2025 Q4	$7.04M	Hold	190,000	–	–	0.06%	260
2025 Q3	$6.85M	Hold	190,000	–	–	0.06%	271
2025 Q2	$6.16M	Hold	190,000	–	–	0.06%	291
2025 Q1	$5.61M	Hold	190,000	–	–	0.06%	296
2024 Q4	$5.59M	Hold	190,000	–	–	0.05%	295
2024 Q3	$5.8M	Hold	190,000	–	–	0.06%	303
2024 Q2	$5.59M	Hold	190,000	–	–	0.06%	306
2024 Q1	$5.45M	Hold	190,000	–	–	0.05%	314
2023 Q4	$4.99M	Hold	190,000	–	–	0.05%	324
2023 Q3	$4.56M	Hold	190,000	–	–	0.05%	324
2023 Q2	$4.75M	Hold	190,000	–	–	0.05%	324
2023 Q1	$4.36M	Hold	190,000	–	–	0.05%	345
2022 Q4	$3.78M	Hold	190,000	–	–	0.04%	384
2022 Q3	$3.49M	Hold	190,000	–	–	0.04%	379
2022 Q2	$190K	Hold	190,000	–	–	﹤0.01%	1234
2022 Q1	$4.59M	Buy	+190,000	New	+$4.56M	0.24%	30

Other funds holding WRND

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

New York Life Investment Management's WRND Position: Q2 2026 in Review

New York Life Investment Management increased its IQ Global Equity R&D Leaders ETF (WRND) stake by 100% in Q2 2026, buying an estimated $7.78M and bringing the position to 380,000 shares worth $16M. The position accounts for 0.11% of the portfolio, ranked #155.

New York Life Investment Management first reported a position in WRND in Q1 2022 and has held it in 18 quarters since. 5 funds tracked by Wall St. Rank hold WRND as of Q2 2026.

New York Life Investment Management held 380,000 shares of IQ Global Equity R&D Leaders ETF worth $16M as of Q2 2026.
New York Life Investment Management bought 190,000 IQ Global Equity R&D Leaders ETF shares in Q2 2026, an estimated $7.78M.
IQ Global Equity R&D Leaders ETF made up 0.11% of New York Life Investment Management's portfolio in Q2 2026, its #155 holding.
New York Life Investment Management first reported a position in IQ Global Equity R&D Leaders ETF in Q1 2022 and has held it in 18 quarters since.
5 funds tracked by Wall St. Rank held IQ Global Equity R&D Leaders ETF as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.